26857415|t|Early differential diagnosis between Alzheimer's disease and dementia with Lewy bodies: Comparison between (18)F-FDG PET and (123)I-IMP SPECT.
26857415|a|Both (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) and (123)I-iodoamphetamine (IMP) single-photon emission computed tomography (SPECT) have been used for the differential diagnosis of Alzheimer's disease (AD) and dementia with Lewy bodies (DLB). Less information is available, however, regarding the differential diagnosis of mild cognitive impairment (MCI) due to AD and MCI due to DLB. We examined nine AD patients (AD group), nine DLB patients (DLB group), eight MCI due to AD patients (MCI-AD group), and nine MCI due to DLB patients (MCI-DLB group) with FDG PET and IMP SPECT using a well-characterized normal database and a stereotactic extraction estimation method. In the AD and DLB groups, receiver operating characteristic (ROC) analysis in the occipital regions showed significant accuracy of both FDG PET and IMP SPECT for the differential diagnosis. In the MCI-AD and MCI-DLB groups, ROC analysis showed significant accuracy of only FDG PET for the differential diagnosis. Both FDG PET and IMP SPECT would be useful for the differential diagnosis between AD and DLB. For the differential diagnosis of MCI-AD versus MCI-DLB, FDG PET would be more useful than IMP SPECT. 
26857415	37	56	Alzheimer's disease	Disease	MESH:D000544
26857415	61	86	dementia with Lewy bodies	Disease	MESH:D020961
26857415	107	116	(18)F-FDG	Chemical	-
26857415	125	135	(123)I-IMP	Chemical	-
26857415	148	172	(18)F-fluorodeoxyglucose	Chemical	MESH:D019788
26857415	174	177	FDG	Chemical	-
26857415	218	240	(123)I-iodoamphetamine	Chemical	-
26857415	242	245	IMP	Chemical	-
26857415	347	366	Alzheimer's disease	Disease	MESH:D000544
26857415	368	370	AD	Disease	MESH:D000544
26857415	376	401	dementia with Lewy bodies	Disease	MESH:D020961
26857415	403	406	DLB	Disease	MESH:D020961
26857415	489	514	mild cognitive impairment	Disease	MESH:D060825
26857415	516	519	MCI	Disease	MESH:D060825
26857415	528	530	AD	Disease	MESH:D000544
26857415	535	538	MCI	Disease	MESH:D060825
26857415	546	549	DLB	Disease	MESH:D020961
26857415	568	570	AD	Disease	MESH:D000544
26857415	571	579	patients	Species	9606
26857415	581	583	AD	Disease	MESH:D000544
26857415	597	600	DLB	Disease	MESH:D020961
26857415	601	609	patients	Species	9606
26857415	611	614	DLB	Disease	MESH:D020961
26857415	629	632	MCI	Disease	MESH:D060825
26857415	640	642	AD	Disease	MESH:D000544
26857415	643	651	patients	Species	9606
26857415	653	656	MCI	Disease	MESH:D060825
26857415	657	659	AD	Disease	MESH:D000544
26857415	677	680	MCI	Disease	MESH:D060825
26857415	688	691	DLB	Disease	MESH:D020961
26857415	692	700	patients	Species	9606
26857415	702	705	MCI	Disease	MESH:D060825
26857415	706	709	DLB	Disease	MESH:D020961
26857415	722	725	FDG	Chemical	-
26857415	734	737	IMP	Chemical	-
26857415	843	845	AD	Disease	MESH:D000544
26857415	850	853	DLB	Disease	MESH:D020961
26857415	972	975	FDG	Chemical	-
26857415	984	987	IMP	Chemical	-
26857415	1033	1036	MCI	Disease	MESH:D060825
26857415	1037	1039	AD	Disease	MESH:D000544
26857415	1044	1047	MCI	Disease	MESH:D060825
26857415	1048	1051	DLB	Disease	MESH:D020961
26857415	1109	1112	FDG	Chemical	-
26857415	1154	1157	FDG	Chemical	-
26857415	1166	1169	IMP	Chemical	-
26857415	1231	1233	AD	Disease	MESH:D000544
26857415	1238	1241	DLB	Disease	MESH:D020961
26857415	1277	1280	MCI	Disease	MESH:D060825
26857415	1281	1283	AD	Disease	MESH:D000544
26857415	1291	1294	MCI	Disease	MESH:D060825
26857415	1295	1298	DLB	Disease	MESH:D020961
26857415	1300	1303	FDG	Chemical	-
26857415	1334	1337	IMP	Chemical	-

